衰老和神经退行相关痴呆症的神经epigenetics:一个更新的审查
Fayaz Ahmad Mir1, Ayeman Amanullah2, Buddhi Prakash Jain3
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ageing research reviews
|September 9, 2023
概括
表观遗传变化显著影响大脑功能和记忆. 了解这些变化为与年龄相关的痴呆症和神经退行性疾病提供了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 大脑中的基因表达在记忆过程中发生变化.
- 像表观遗传学这样的非遗传因素在神经退行性疾病 (NDD) 和痴呆症中至关重要.
- 表观遗传修饰调节基因表达,独立于DNA序列.
研究的目的:
- 审查与衰老和痴呆相关的表观遗传变化.
- 突出表观遗传学在NDD和记忆障碍中的作用.
- 探索表观遗传景观作为潜在的治疗目标.
主要方法:
- 审查关于表观遗传学,衰老和痴呆症的当前文献.
- 对表观遗传机制的分析,包括DNA甲基化和基因素乙化.
- 在大脑疾病的背景下检查信使RNA编辑.
主要成果:
- 表观遗传修饰是参与衰老和NDD的基因的关键调节者.
- 表观基因组的变化,特别是中枢神经系统的变化,导致大脑疾病.
- 这些表观遗传改变背后的机制需要进一步研究.
结论:
- 表观遗传调节对于中枢神经系统的功能和适应至关重要.
- 了解表观遗传变化可能会导致对痴呆症和NDD的新型药物遗传治疗.
- 针对表观遗传景观对神经退行性疾病治疗有希望.
相关概念视频
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Neurogenesis and Regeneration of Nervous Tissue
856
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
856
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Aging
86
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
86


